09:54 AM EST - Theralase Technologies Inc. : announced today that it has executed an agreement with the University of Toledo to conduct preclinical research into the safety and effectiveness of Theralase's Photo Dynamic Compounds in the destruction of bladder cancer in a rat model. Theralase Technologies Inc.
shares V.TLT are trading unchanged at $0.33.
